Works matching IS 1021335X AND DT 2022 AND VI 47 AND IP 6
Results: 13
Reduced tumor growth in EP2 knockout mice is related to signaling pathways favoring an increased local anti-tumor immunity in the tumor stroma.
- Published in:
- Oncology Reports, 2022, v. 47, n. 6, p. N.PAG, doi. 10.3892/or.2022.8329
- By:
- Publication type:
- Article
D-allose enhances the efficacy of hydroxychloroquine against Lewis lung carcinoma cell growth by inducing autophagy.
- Published in:
- Oncology Reports, 2022, v. 47, n. 6, p. N.PAG, doi. 10.3892/or.2022.8328
- By:
- Publication type:
- Article
RNA interference-mediated FANCF silencing sensitizes OVCAR3 ovarian cancer cells to adriamycin through increased adriamycin-induced apoptosis dependent on JNK activation.
- Published in:
- Oncology Reports, 2022, v. 47, n. 6, p. N.PAG, doi. 10.3892/or.2022.8327
- By:
- Publication type:
- Article
Icariin inhibits the malignant progression of lung cancer by affecting the PI3K/Akt pathway through the miR-205-5p/PTEN axis.
- Published in:
- Oncology Reports, 2022, v. 47, n. 6, p. N.PAG, doi. 10.3892/or.2022.8326
- By:
- Publication type:
- Article
Bendamustine: A review of pharmacology, clinical use and immunological effects.
- Published in:
- Oncology Reports, 2022, v. 47, n. 6, p. N.PAG, doi. 10.3892/or.2022.8325
- By:
- Publication type:
- Article
MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-β1.
- Published in:
- Oncology Reports, 2022, v. 47, n. 6, p. N.PAG
- By:
- Publication type:
- Article
Cancer cell-induced tissue inhibitor of metalloproteinase-1 secretion by cancer-associated fibroblasts promotes cancer cell migration.
- Published in:
- Oncology Reports, 2022, v. 47, n. 6, p. N.PAG, doi. 10.3892/or.2022.8323
- By:
- Publication type:
- Article
DEK modulates both expression and alternative splicing of cancer-related genes.
- Published in:
- Oncology Reports, 2022, v. 47, n. 6, p. N.PAG, doi. 10.3892/or.2022.8322
- By:
- Publication type:
- Article
Interferon-stimulated gene 15 promotes progression of endometrial carcinoma and weakens antitumor immune response.
- Published in:
- Oncology Reports, 2022, v. 47, n. 6, p. N.PAG, doi. 10.3892/or.2022.8321
- By:
- Publication type:
- Article
EGFR inhibition reverses epithelial-mesenchymal transition, and decreases tamoxifen resistance via Snail and Twist downregulation in breast cancer cells.
- Published in:
- Oncology Reports, 2022, v. 47, n. 6, p. N.PAG, doi. 10.3892/or.2022.8320
- By:
- Publication type:
- Article
Ribosome assembly factor PNO1 is associated with progression and promotes tumorigenesis in triple-negative breast cancer.
- Published in:
- Oncology Reports, 2022, v. 47, n. 6, p. N.PAG, doi. 10.3892/or.2022.8319
- By:
- Publication type:
- Article
Activin A promotes cell proliferation, invasion and migration and predicts poor prognosis in patients with colorectal cancer.
- Published in:
- Oncology Reports, 2022, v. 47, n. 6, p. N.PAG, doi. 10.3892/or.2022.8318
- By:
- Publication type:
- Article
MicroRNA-148a inhibits breast cancer migration and invasion by directly targeting WNT-1.
- Published in:
- Oncology Reports, 2022, v. 47, n. 6, p. N.PAG
- By:
- Publication type:
- Article